論文

査読有り
2012年12月

YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes

ONCOGENE
  • T. Mizuno
  • H. Murakami
  • M. Fujii
  • F. Ishiguro
  • I. Tanaka
  • Y. Kondo
  • S. Akatsuka
  • S. Toyokuni
  • K. Yokoi
  • H. Osada
  • Y. Sekido
  • 全て表示

31
49
開始ページ
5117
終了ページ
5122
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1038/onc.2012.5
出版者・発行元
NATURE PUBLISHING GROUP

Malignant mesothelioma (MM) shows frequent inactivation of the neurofibromatosis type 2 (NF2) -tumor-suppressor gene. Recent studies have documented that the Hippo signaling pathway, a downstream cascade of Merlin (a product of NF2), has a key role in organ size control and carcinogenesis by regulating cell proliferation and apoptosis. We previously reported that MMs show overexpression of Yes-associated protein (YAP) transcriptional coactivator, the main downstream effector of the Hippo signaling pathway, which results from the inactivation of NF2, LATS2 and/or SAV1 genes (the latter two encoding core components of the mammalian Hippo pathway) or amplification of YAP itself. However, the detailed roles of YAP remain unclear, especially the target genes of YAP that enhance MM cell growth and survival. Here, we demonstrated that YAP-knockdown inhibited cell motility, invasion and anchorage-independent growth as well as cell proliferation of MM cells in vitro. We analyzed genes commonly regulated by YAP in three MM cell lines with constitutive YAP-activation, and found that the major subsets of YAP-upregulating genes encode cell cycle regulators. Among them, YAP directly induced the transcription of CCND1 and FOXM1, in cooperation with TEAD transcription factor. We also found that knockdown of CCND1 and FOXM1 suppressed MM cell proliferation, although the inhibitory effects were less evident than those of YAP knockdown. These results indicate that constitutive YAP activation in MM cells promotes cell cycle progression giving more aggressive phenotypes to MM cells. Oncogene (2012) 31, 5117-5122; doi:10.1038/onc.2012.5; published online 30 January 2012

リンク情報
DOI
https://doi.org/10.1038/onc.2012.5
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000312000900008&DestApp=WOS_CPL
ID情報
  • DOI : 10.1038/onc.2012.5
  • ISSN : 0950-9232
  • Web of Science ID : WOS:000312000900008

エクスポート
BibTeX RIS